Featuring a new 15 minute presentation from within Solentim’s laboratories on the subject of clonality in stem cell-based workflows, with a special focus on iPSCs.
iPSCs have practically an unlimited proliferation potential, and a capability to differentiate into any cell type in the human body. Because of this, iPSCs have become a major focus in nearly all disease areas, with research in disease models for future patient cell therapy applications. iPSC technology will continue to play a critical role in this field in the future.
Enjoy the virtual demonstration and download the resources!